{
  "meta": {
    "title": "Miscellaneous_Endocrinology",
    "url": "https://brainandscalpel.vercel.app/miscellaneous-endocrinology-a779b858.html",
    "scrapedAt": "2025-11-30T11:13:09.775Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune polyendocrine syndrome</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\"> Acromegaly</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">MEN 2A</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">MEN type 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman presents with a 6-month history of galactorrhoea. She also complains of a 5-year history of dyspepsia and persistent use of PPIs. Examination reveals a BMI of 23.5 kg/m2, and galactorrhoea was noticed. Slight neck enlargement was noticed during examination. Investigations show:<br>prolactin: 980 mU/l (50-500 mU/l)<br>estradiol: 85 pmol/l (130-500)<br>LH of 3.1 mU/l (3.5-8)<br>FSH of 2.8 mU/l (3-8)<br>Serum calcium: 11.2 mg/dl (8.5-10.5)<br>Ultrasonography revealed a parathyroid enlargement and a 99mTcO4/MIBI scan showed <br>two hyperplastic lesions.<br>What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196858",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196858,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The triad of <strong>prolactinoma</strong>, <strong>hyperparathyroidism</strong>, and probable <strong>gastrinoma</strong> (due to chronic dyspepsia and PPI use) is diagnostic of <strong>MEN type 1</strong>.<strong><br /> Multiple Endocrine Neoplasia type 1 (MEN 1)</strong> is a hereditary disorder caused by mutations in the <strong>MEN1 gene</strong> (menin protein), with <strong>autosomal dominant</strong> inheritance.</p>\r\n<ul>\r\n<li>The classical triad includes:\r\n<ul>\r\n<li><strong>Pituitary tumors</strong> (e.g., prolactinoma, acromegaly)</li>\r\n<li><strong>Parathyroid hyperplasia/adenomas</strong> (&rarr; hypercalcemia)</li>\r\n<li><strong>Pancreatic neuroendocrine tumors</strong> (e.g., <strong>gastrinoma</strong>, insulinoma)</li>\r\n</ul>\r\n</li>\r\n<li>In this patient:\r\n<ul>\r\n<li><strong>Galactorrhoea + raised prolactin + low gonadotropins</strong> &rarr; Prolactinoma</li>\r\n<li><strong>Hypercalcemia + parathyroid hyperplasia</strong> &rarr; Hyperparathyroidism</li>\r\n<li><strong>Dyspepsia requiring PPI for 5 years</strong> &rarr; suggests <strong>Zollinger-Ellison syndrome</strong> from <strong>gastrinoma</strong><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024042263ec88e0-10ac-45f4-b549-8b387cea1298.jpg\"></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Autoimmune polyendocrine syndrome (Option A):</strong> Typically includes <strong>Addison's disease</strong>, <strong>hypoparathyroidism</strong>, and <strong>mucocutaneous candidiasis</strong>-not seen here.</p>\r\n<p><strong>Acromegaly (Option B):</strong> Would present with <strong>GH excess</strong>, not isolated prolactin elevation or parathyroid and gastrin-related features.</p>\r\n<p><strong>MEN 2A (Option C):</strong> Includes <strong>medullary thyroid carcinoma</strong>, <strong>pheochromocytoma</strong>, and <strong>parathyroid hyperplasia</strong>, but <strong>pituitary tumors and gastrinomas are not features</strong>.</p>\r\n<p><strong>Key Takeaway:<br /> </strong><strong>MEN type 1</strong> presents with <strong>pituitary</strong>, <strong>parathyroid</strong>, and <strong>pancreatic (gastrinoma)</strong> tumors-the findings in this case strongly support that diagnosis.</p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullar carcinoma of thyroid</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Parathyroid hyperplasia</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreatic islet-cell tumour</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary adenoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 47-year-old woman is complaining of fatigue and weight loss. She was successfully treated medically for a prolactinoma 3 years ago, and it is suspected that she might now have MEN-1. Which of the following underlying conditions is she most likely to have?</span></p>",
      "unique_key": "DT1196863",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196863,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The patient has a <strong>history of prolactinoma</strong>, which is a <strong>pituitary tumor</strong>-one of the key components of <strong>MEN-1</strong>. Among the <strong>three classic manifestations of MEN-1</strong> (pituitary, parathyroid, pancreatic), <strong>parathyroid hyperplasia</strong> is:</p>\r\n<ul>\r\n<li>The <strong>most common</strong> and <strong>earliest</strong> manifestation of MEN-1</li>\r\n<li>Leads to <strong>primary hyperparathyroidism</strong> and resultant <strong>hypercalcemia</strong></li>\r\n<li>May present with <strong>fatigue, depression, weight loss, or nephrolithiasis</strong></li>\r\n</ul>\r\n<p>Although pancreatic islet tumors (e.g., gastrinomas, insulinomas) and pituitary tumors are also seen, <strong>parathyroid hyperplasia is present in &gt;90%</strong> of MEN-1 patients and is usually the <strong>first manifestation</strong>.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250918c9ee4037-fec8-497d-a248-f52723f716af.png\">\r\n<ul>\r\n<li>MEN-1 is due to a <strong>mutation in the MEN1 gene (menin)</strong></li>\r\n<li>Inherited in an <strong>autosomal dominant</strong> pattern</li>\r\n<li>Medullary carcinoma of thyroid is seen in <strong>MEN-2</strong>, not MEN-1</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Medullary carcinoma of thyroid (Option A):</strong> Seen in <strong>MEN-2</strong>, not MEN-1.</p>\r\n<p><strong>Pancreatic islet-cell tumour (Option C):</strong> Common in MEN-1, but <strong>less frequent</strong> than parathyroid involvement.</p>\r\n<p><strong>Pituitary adenoma (Option D):</strong> Already present in this patient; question asks about the <strong>most likely associated new condition</strong>.</p>\r\n<p><strong>Key Takeaway:<br /> </strong><strong>Parathyroid hyperplasia</strong> is the <strong>most frequent and earliest</strong> endocrine abnormality in <strong>MEN-1</strong>, often causing <strong>asymptomatic hypercalcemia</strong>.</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Simple traumatic retinal detachment</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Clotting disorder</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleeding due to hypertension</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Hippel-Lindau syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old man presents to casualty with a sudden loss of vision in his right eye. His only history of note is a previous cerebellar haemorrhage. On examination, he has Blood pressure of 130/86 mmHg, evidence of bilateral retinal angiomas, and a partial retinal detachment in his right eye. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1196864",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196864,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient has <strong>classic features of Von Hippel&ndash;Lindau (VHL) syndrome</strong>, a <strong>rare autosomal dominant disorder</strong> caused by mutations in the <strong>VHL tumor suppressor gene</strong>:</p>\r\n<ul>\r\n<li><strong>Retinal hemangioblastomas (angiomas)</strong> &rarr; may cause <strong>exudative retinal detachment</strong> or vision loss</li>\r\n<li><strong>CNS hemangioblastomas</strong>, especially in the <strong>cerebellum</strong> &rarr; prior cerebellar hemorrhage supports this</li>\r\n<li><strong>Renal cell carcinoma</strong> (especially clear cell type)</li>\r\n<li><strong>Pheochromocytomas</strong> (seen in ~20% of families, often bilateral)</li>\r\n<li><strong>Pancreatic cysts or neuroendocrine tumors</strong></li>\r\n</ul>\r\n<p>The <strong>mean age of presentation</strong> is in the 2nd to 3rd decade, consistent with this case.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250918c4ab90ea-3115-4501-bffb-49183e0302d5.png\">\r\n<ul>\r\n<li>VHL is classified as a <strong>phakomatosis (neurocutaneous syndrome)</strong></li>\r\n<li>Early diagnosis is critical to prevent vision loss and manage tumors</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Simple traumatic retinal detachment (Option A):</strong> No trauma history; bilateral angiomas point to an inherited cause.</p>\r\n<p><strong>Clotting disorder (Option B):</strong> Could explain hemorrhage, but not retinal angiomas or this specific tumor profile.</p>\r\n<p><strong>Bleeding due to hypertension (Option C):</strong> BP is normal; hypertensive retinopathy is unlikely at this age with this BP.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>VHL syndrome</strong> should be suspected in <strong>young patients</strong> with <strong>retinal angiomas</strong>, <strong>CNS hemorrhage</strong>, and <strong>retinal detachment</strong>.</p>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\"> Prolactinoma</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary cancer of thyroid</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucagonomas</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Parathyroid hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of MEN-1?</span></p>",
      "unique_key": "DT1196870",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196870,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Medullary thyroid carcinoma</strong> is characteristic of <strong>MEN 2</strong>, not <strong>MEN 1</strong>.</p>\r\n<p><strong>Multiple Endocrine Neoplasia type 1 (MEN-1)</strong> is also called <strong>Werner's syndrome</strong> and is caused by mutations in the <strong>MEN1 gene</strong> encoding <strong>menin</strong>. It is inherited in an <strong>autosomal dominant</strong> pattern.</p>\r\n<p><strong>Classic triad of MEN 1</strong> involves the <strong>3 Ps</strong>:</p>\r\n<ol>\r\n<li><strong>Parathyroid hyperplasia/adenoma</strong> &rarr; hypercalcemia (most common feature, ~90%) <strong>(Option D)</strong></li>\r\n<li><strong>Pituitary tumors</strong> &rarr; mostly <strong>prolactinomas</strong>, but also GH-secreting or non-functioning adenomas<strong> (Option A)</strong></li>\r\n<li><strong>Pancreatic neuroendocrine tumors</strong> &rarr; gastrinomas, insulinomas, glucagonomas, VIPomas <strong>(Option C)</strong></li>\r\n</ol>\r\n<ul>\r\n<li><strong>Glucagonomas</strong> cause <strong>hyperglycemia</strong>, <strong>weight loss</strong>, and <strong>necrolytic migratory erythema</strong></li>\r\n<li><strong>MEN 2</strong>, not MEN 1, is associated with <strong>medullary thyroid carcinoma</strong>, pheochromocytoma, and marfanoid features</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Medullary thyroid carcinoma</strong> is a hallmark of <strong>MEN 2</strong>, not <strong>MEN 1</strong>, which primarily involves <strong>parathyroid, pituitary, and pancreatic tumors</strong>.</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">MEN-1</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">MEN-2a</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">MEN-2b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman presents to the emergency department after brisk running. Her blood pressure is noted to be 185/110 mmHg on admission. She admits to episodic headaches and feeling stressed and anxious. She is of normal appearance. Her serum calcium on admission is noted to be 12 mg/dl with normal renal function. Abdominal ultrasound reveals a possible adrenal mass.<br>What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1196873",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196873,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The combination of <strong>pheochromocytoma (adrenal mass + paroxysmal HTN)</strong> and <strong>hypercalcemia</strong> suggests <strong>MEN-2A</strong>, which involves both <strong>parathyroid hyperplasia</strong> and <strong>pheochromocytoma</strong>.<strong><br /> Multiple Endocrine Neoplasia type 2A (MEN-2A)</strong> is an <strong>autosomal dominant</strong> syndrome caused by <strong>RET proto-oncogene mutation on chromosome 10</strong>.</p>\r\n<p><strong>MEN-2A triad:</strong></p>\r\n<ol>\r\n<li><strong>Medullary thyroid carcinoma (MTC)</strong> - 100% penetrance</li>\r\n<li><strong>Pheochromocytoma</strong> - ~50%</li>\r\n<li><strong>Parathyroid hyperplasia</strong> - ~20-30%</li>\r\n</ol>\r\n<p>In this patient:</p>\r\n<ul>\r\n<li><strong>Adrenal mass + episodic headache + paroxysmal HTN</strong> &rarr; <strong>Pheochromocytoma</strong></li>\r\n<li><strong>Hypercalcemia</strong> &rarr; likely <strong>parathyroid hyperplasia</strong></li>\r\n<li>These two together strongly suggest <strong>MEN-2A</strong></li>\r\n</ul>\r\n<p><strong>Workup should include:</strong></p>\r\n<ul>\r\n<li><strong>Plasma metanephrines</strong></li>\r\n<li><strong>Serum calcitonin and neck ultrasound</strong> for medullary carcinoma</li>\r\n<li><strong>RET gene testing</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Pheochromocytoma (Option A):</strong> Seen here, but <strong>does not explain hypercalcemia</strong>.</p>\r\n<p><strong>MEN-1 (Option B):</strong> Involves <strong>parathyroid, pituitary, and pancreatic tumors</strong>, not pheochromocytoma or MTC.</p>\r\n<p><strong>MEN-2B (Option D):</strong> Involves <strong>pheochromocytoma and MTC</strong>, but <strong>also has marfanoid habitus and mucosal neuromas</strong>, which are <strong>absent here</strong>.</p>\r\n<p><strong>Key Takeaway:<br /> </strong> <strong>MEN-2A</strong> involves <strong>pheochromocytoma</strong>, <strong>parathyroid hyperplasia</strong>, and <strong>medullary thyroid carcinoma</strong>, and is suggested by <strong>hypercalcemia + adrenal mass + hypertension</strong>.</p>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal tubular acidosis Type 4</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary sponge kidney</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal tubular acidosis Type 2</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal tubular acidosis Type 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old woman with Hashimoto's thyroiditis presents to the clinic for review. She is managed with thyroxine 125 mcg/day replacement. She presents to the clinic complaining of bilateral loin pain.<br>Investigations;<br>Hb 12.1 g/dl<br>WCC 5.4 x 10^9/L<br>PLT 294 x 10^9/L<br>Na+ 139 mmol/l<br>K+ 3.3 mmol/l<br>Creatinine 1.40 mg/dl<br>HCO3- 15 mmol/l<br>KUB Evidence of nephrocalcinosis<br>Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "DT1196886",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196886,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Distal (Type 1) RTA</strong> is associated with <strong>hypokalemia, metabolic acidosis, nephrocalcinosis</strong>, and <strong>autoimmune disorders</strong> like <strong>Hashimoto&rsquo;s thyroiditis</strong>.<strong><br /> Renal tubular acidosis (RTA)</strong> refers to normal anion gap (hyperchloremic) metabolic acidosis due to defective renal acid handling.</p>\r\n<p><strong>RTA Type 1 (Distal RTA):</strong></p>\r\n<ul>\r\n<li>Defect in H+secretion in distal nephron</li>\r\n<li>Hypokalemia, low bicarbonate, normal anion gap metabolic acidosis</li>\r\n<li>Hypercalciuria and alkaline urine &rarr; nephrocalcinosis, renal stones</li>\r\n<li>Associated with autoimmune diseases: Sj&ouml;gren's syndrome, Hashimoto's thyroiditis, SLE</li>\r\n</ul>\r\n<p>This patient presents with:</p>\r\n<ul>\r\n<li>Autoimmune hypothyroidism (Hashimoto's)</li>\r\n<li>Hypokalemia</li>\r\n<li>Low bicarbonate</li>\r\n<li>Nephrocalcinosis<br /> &rarr; Classic for <strong>Type 1 RTA</strong></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250918810a42f7-b393-47ab-83dc-cf1f0e353a41.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>RTA Type 4 (Option A):</strong> Causes hyperkalemia, not seen here.</p>\r\n<p><strong>Medullary sponge kidney (Option B):</strong> May cause <strong>nephrocalcinosis</strong>, but not associated with <strong>acidosis or hypokalemia</strong>.</p>\r\n<p><strong>RTA Type 2 (Option C):</strong> <strong>Proximal RTA</strong> with <strong>bicarbonate wasting</strong>, but <strong>not typically associated with nephrocalcinosis or autoimmune thyroiditis</strong>.</p>\r\n<p><strong>Key Takeaway:<br /> </strong> <strong>Distal RTA (Type 1)</strong> is the only form of RTA associated with <strong>nephrocalcinosis</strong>, <strong>hypokalemia</strong>, <strong>metabolic acidosis</strong>, and <strong>autoimmune diseases</strong> like <strong>Hashimoto's thyroiditis</strong>.</p>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple endocrine neoplasia (MEN)-type II syndrome</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Phaeochromocytoma</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulinoma</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudodementia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 71-year-old man is admitted to hospital in a comatose condition. His wife gives a history of past episodes of sweating and palpitations, confusion, and occasional abnormal behaviour that improves with intake of glucose.. On examination, his pulse is 92 bpm and his blood pressure is 140/90 mmHg. His plasma catecholamine level is normal, and blood glucose is 65 mg/dl. What is the most probable diagnosis?</span></p>",
      "unique_key": "DT1196894",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196894,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Symptoms relieved by glucose in the setting of low blood sugar strongly indicate <strong>hypoglycemia due to insulinoma</strong>, especially when <strong>Whipple's triad</strong> is met.<strong><br /> </strong>This patient's symptoms suggest <strong>recurrent hypoglycemia</strong> with both autonomic and neuroglycopenic features:</p>\r\n<ul>\r\n<li><strong>Whipple's triad</strong>:\r\n<ul>\r\n<li>Hypoglycemic symptoms (sweating, confusion, behavior change)</li>\r\n<li>Low plasma glucose (&lt;70 mg/dL)</li>\r\n<li>Symptom relief with glucose intake</li>\r\n</ul>\r\n</li>\r\n<li><strong>Insulinoma</strong> is the most common islet-cell tumor causing endogenous hyperinsulinemia</li>\r\n<li>Often <strong>benign</strong>, but may be associated with <strong>MEN1</strong></li>\r\n<li><strong>Plasma catecholamines are normal</strong>, ruling out pheochromocytoma</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>MEN-II syndrome (Option A):</strong> Associated with <strong>medullary thyroid carcinoma, pheochromocytoma</strong>, and <strong>parathyroid hyperplasia</strong>, not hypoglycemia.</p>\r\n<p><strong>Phaeochromocytoma (Option B):</strong> Typically presents with <strong>episodic hypertension, palpitations, headache</strong> not hypoglycemia.</p>\r\n<p><strong>Pseudodementia (Option D):</strong> Mimics dementia but is due to <strong>major depression</strong>, not relieved by glucose and not associated with autonomic symptoms.</p>\r\n<p><strong>Key Takeaway:<br /> </strong> <strong>Insulinoma</strong> should be suspected in any patient with recurrent neuroglycopenic and autonomic symptoms relieved by glucose <strong>Whipple's triad is key</strong> to diagnosis.</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation of a muscle voltage-gated sodium channel</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation in a muscle voltage-gated potassium channel</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation in a renal potassium channel</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation in a muscle voltage-gated calcium channel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old student is brought to emergency after he had been playing that afternoon, and while resting (after having had a pasta meal), complained of generalised weakness. He was unable to stand and had to be carried in by his friends. His potassium level was noted to be 2.1 mmol/l. Urine screen for diabetic and laxative abuse was normal. He has had similar attacks since his early teenage years. Symptoms were aborted by potassium chloride. What type of mutation best fits the underlying pathology of this autosomal-dominant condition involving intermittent paralysis?</span></p>",
      "unique_key": "DT1196898",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196898,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Hypokalemic periodic paralysis</strong> is classically caused by mutations in the <strong>CACNA1S</strong> gene encoding the <strong>skeletal muscle voltage-gated calcium channel</strong>.</p>\r\n<ul>\r\n<li>The patient exhibits <strong>episodic flaccid weakness</strong> triggered by <strong>high carbohydrate intake</strong> or <strong>rest after exertion</strong>, with documented <strong>hypokalemia</strong></li>\r\n<li>This points to <strong>Hypokalemic Periodic Paralysis</strong>, an <strong>autosomal dominant</strong> channelopathy</li>\r\n<li>Most commonly due to mutations in the <strong>CACNA1S</strong> gene &rarr; affecting <strong>voltage-gated calcium channels</strong> in skeletal muscle</li>\r\n<li>Symptoms:\r\n<ul>\r\n<li>Recurrent attacks of <strong>flaccid paralysis</strong> lasting hours</li>\r\n<li>Often starts in <strong>adolescence</strong></li>\r\n<li>Triggers include <strong>high-carb meals</strong>, <strong>rest after exercise</strong>, <strong>stress</strong></li>\r\n</ul>\r\n</li>\r\n<li>Potassium supplementation provides rapid symptomatic relief</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Muscle sodium channel mutation (Option A):</strong> Seen in <strong>Hyperkalemic periodic paralysis</strong>, not the hypokalemic form</p>\r\n<p><strong>Muscle potassium channel mutation (Option B):</strong> Associated with <strong>Andersen-Tawil syndrome</strong>, features dysmorphism and arrhythmias-not classic for this case</p>\r\n<p><strong>Renal potassium channel mutation (Option C):</strong> Does not explain <strong>episodic paralysis</strong>-seen in disorders like Bartter syndrome</p>\r\n<p><strong>Key Takeaway:<br /> </strong> <strong>Hypokalemic periodic paralysis</strong> is commonly caused by a mutation in the <strong>CACNA1S gene</strong> encoding <strong>skeletal muscle voltage-gated calcium channels</strong>.</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Somatostatin, ACTH and calcitonin may all be raised</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Contrast spiral-CT scanning is effective in demonstrating the primary tumour in 90% of cases</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Curative surgery is possible in the majority of casess</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">There is almost always an association with MEN-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old woman presents to the diabetes clinic for review. She has suffered from diabetes mellitus for many years and has now progressed from sulphonylurea treatment to insulin therapy. A history of gallstones is noted, and she failed to tolerate metformin due to chronic diarrhoea. She has been slowly losing weight over the past few months and has mild anaemia. Ultrasound scan of her liver reveals a suggestion of several small metastases within the liver. When considering that this woman has a primary pancreatic tumour, which of the following statements best fits the condition?</span></p>",
      "unique_key": "DT1196902",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196902,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient likely has a <strong>somatostatinoma</strong>, a rare pancreatic endocrine tumor with characteristic features such as <strong>diabetes, gallstones, diarrhea, weight loss, and anemia</strong>.</p>\r\n<ul>\r\n<li>Somatostatinomas are <strong>extremely rare</strong> tumors with an incidence of ~1 per 40 million per year</li>\r\n<li>Typical features include:\r\n<ul>\r\n<li><strong>Diabetes or impaired glucose tolerance</strong> (seen in up to 95%)</li>\r\n<li><strong>Gallstones</strong> (due to inhibition of cholecystokinin)</li>\r\n<li><strong>Weight loss</strong> (25%) and <strong>anemia</strong> (14%)</li>\r\n<li><strong>Chronic diarrhea</strong> due to inhibition of multiple gastrointestinal hormones</li>\r\n</ul>\r\n</li>\r\n<li>These tumors can be <strong>multi-secretory</strong>, with elevated levels of <strong>somatostatin</strong>, <strong>ACTH</strong>, and <strong>calcitonin</strong></li>\r\n<li>Liver metastases are common at presentation, reducing chances of curative surgery</li>\r\n<li><strong>MEN-1 association</strong> is rare (~7%), unlike insulinomas or gastrinomas <strong>(Option D ruled out)</strong></li>\r\n<li><strong>Contrast spiral-CT</strong> detects the primary tumor in <strong>~50%</strong> of cases-not 90%<strong>(Option B ruled out)</strong></li>\r\n<li><strong>DOTATATE PET</strong> or <strong>endoscopic ultrasound</strong> may be more sensitive</li>\r\n<li>Treatment may involve <strong>hepatic embolization</strong> for palliation</li>\r\n<li>Curative surgery rare due to early metastasis at presentation <strong>(Option C ruled out)</strong></li>\r\n</ul>\r\n<p><strong>Key Takeaway:<br /> </strong> <strong>Somatostatinomas</strong> often present with diabetes, gallstones, and diarrhea, and may secrete <strong>somatostatin, ACTH, and calcitonin</strong>.</p>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic fatigue syndrome</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Myasthenia gravis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old banker presents to the clinic. Apart from a history of reflux symptoms, her previous medical history is unremarkable. She gives a history of increasing fatigue, being sometimes unable to leave her bedroom. She feels unable to concentrate, has headaches, intermittent sore throats and feels that when she can sleep, she awakens unrefreshed. Full blood count, viscosity, urea and electrolytes, liver function testing, thyroid function testing and a Synacthen test have all been normal. On examination in the clinic, there are no abnormal physical findings in this normal-weight, normal-height young woman. What diagnosis fits best with this clinical picture?</span></p>",
      "unique_key": "DT1196908",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196908,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>A young adult with profound fatigue, unrefreshing sleep, and normal physical and lab findings strongly suggests <strong>chronic fatigue syndrome (CFS)</strong>.</p>\r\n<ul>\r\n<li>CFS typically affects <strong>young to middle-aged adults</strong>, with a <strong>female preponderance</strong></li>\r\n<li>Often follows a <strong>flu-like illness</strong>; a <strong>viral trigger</strong> (e.g., EBV) is suspected, though not proven</li>\r\n<li>Patients report:\r\n<ul>\r\n<li><strong>Severe fatigue</strong> not relieved by rest</li>\r\n<li><strong>Cognitive dysfunction</strong>, often described as'brain fog'</li>\r\n<li><strong>Sleep disturbances</strong>, where sleep is unrefreshing</li>\r\n<li><strong>Myalgia, sore throat</strong>, and <strong>headaches</strong></li>\r\n</ul>\r\n</li>\r\n<li>All <strong>routine investigations</strong> are typically <strong>normal</strong>, including:\r\n<ul>\r\n<li>Thyroid function</li>\r\n<li>Synacthen test (rules out Addison's)</li>\r\n<li>Blood counts, liver, and renal parameters</li>\r\n</ul>\r\n</li>\r\n<li><strong>Diagnosis is clinical</strong> and one of exclusion</li>\r\n<li><strong>Management</strong> includes:\r\n<ul>\r\n<li><strong>Patient education</strong>, cognitive behavioral therapy</li>\r\n<li><strong>Graded exercise therapy</strong></li>\r\n<li>Low-dose <strong>tricyclics</strong> (e.g., amitriptyline) may be useful for sleep and pain</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Addison's disease (Option A):</strong> Ruled out by normal <strong>Synacthen test</strong></p>\r\n<p><strong>Hypothyroidism (Option B):</strong> Ruled out by <strong>normal thyroid profile</strong></p>\r\n<p><strong>Myasthenia gravis (Option D):</strong> Would present with <strong>fluctuating muscle weakness</strong> (e.g., <strong>ptosis</strong>, <strong>diplopia</strong>)-not generalized fatigue alone</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Chronic fatigue syndrome</strong> presents with debilitating fatigue and unrefreshing sleep in the absence of any objective abnormalities on examination or routine tests.</p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Anorexia nervosa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 19-year-old girl referred for evaluation of menstrual disturbances. She weighs only 38 kg and is 1.78 m tall. She is emaciated, her skin is dry, and she has excessive growth of lanugo hair. She has been amenorrhoeic for 9 months. Her cortisol level is elevated, her Free T4 is normal. She has anaemia and associated reduced white cell and platelet count. Which of the following diagnoses is most likely to fit with this clinical picture?</span></p>",
      "unique_key": "DT1196913",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196913,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient presents with <strong>classic signs of anorexia nervosa</strong>, a psychiatric disorder with profound medical consequences:</p>\r\n<ul>\r\n<li><strong>Severe underweight (BMI &lt; 17.5)</strong></li>\r\n<li><strong>Amenorrhea &gt;3 months</strong></li>\r\n<li><strong>Lanugo hair</strong> (fine, soft body hair seen with nutritional deficiency)</li>\r\n<li><strong>Dry skin, bradycardia, hypotension</strong> (autonomic and hormonal dysfunction)</li>\r\n<li><strong>Pancytopenia</strong> due to bone marrow suppression</li>\r\n<li><strong>Cortisol elevated</strong>, but <strong>TSH and Free T4 remain normal</strong> (non-thyroidal illness pattern)</li>\r\n</ul>\r\n<p>Anorexia nervosa involves:</p>\r\n<ul>\r\n<li>Low levels of <strong>FSH, LH, and estrogen</strong></li>\r\n<li><strong>Metabolic alkalosis</strong>, <strong>hypokalemia</strong>, <strong>hypomagnesemia</strong>, and <strong>hypocalcemia</strong></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509187c40b02c-c0ad-462a-aaee-840830b5a302.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Addison's disease (Option A):</strong> Causes weight loss and hyperpigmentation but not amenorrhea, lanugo, or normal thyroid function</p>\r\n<p><strong>HIV (Option B):</strong> May cause weight loss and cytopenias, but not classic for lanugo, amenorrhea, or hormonal profile</p>\r\n<p><strong>Hypothyroidism (Option C):</strong> Causes dry skin and amenorrhea, but would show <strong>low Free T4</strong>, <strong>not elevated cortisol</strong>, and not lanugo or extreme weight loss</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Anorexia nervosa should be suspected in young females with extreme weight loss, amenorrhea, lanugo hair, and hematologic abnormalities.</p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Addison disease</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcoholism</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">SLE</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyrotoxicosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a cause for secondary hypertriglyceridemia?</span></p>",
      "unique_key": "DT1196922",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196922,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Chronic alcohol use</strong> is a well-known cause of <strong>secondary hypertriglyceridemia</strong>, mainly due to <strong>increased hepatic VLDL production</strong>.</p>\r\n<p><strong>Hypertriglyceridemia</strong> may be <strong>primary (genetic)</strong> or <strong>secondary (acquired)</strong>. Secondary causes include:</p>\r\n<ul>\r\n<li><strong>Type 2 diabetes mellitus</strong></li>\r\n<li><strong>Chronic renal failure</strong></li>\r\n<li><strong>Alcoholism</strong></li>\r\n<li><strong>Hypothyroidism</strong> (mainly hypercholesterolemia)</li>\r\n<li><strong>Nephrotic syndrome</strong> (mainly hypercholesterolemia)</li>\r\n<li><strong>Drugs</strong>: thiazides, corticosteroids, estrogens, cyclosporine, protease inhibitors</li>\r\n</ul>\r\n<p>In <strong>alcoholism</strong>, the <strong>metabolism of ethanol increases hepatic NADH</strong>, promoting <strong>fatty acid synthesis</strong> and <strong>triglyceride production</strong>. This leads to <strong>VLDL overproduction</strong> and elevated <strong>plasma triglycerides</strong>.</p>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Addison disease (Option A):</strong> Causes <strong>hypoglycemia and weight loss</strong>, not associated with hypertriglyceridemia.</p>\r\n<p><strong>SLE (Option C):</strong> Can cause <strong>secondary dyslipidemia</strong> due to steroid therapy, but not a direct cause of isolated hypertriglyceridemia.</p>\r\n<p><strong>Thyrotoxicosis (Option D):</strong> Tends to <strong>lower LDL and triglycerides</strong>; <strong>hypothyroidism</strong>, not hyperthyroidism, is linked to lipid disorders.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Alcoholism</strong> is a major <strong>secondary cause of hypertriglyceridemia</strong>, through hepatic overproduction of <strong>VLDL</strong>.</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Marked hypercholesterolemia</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced chylomicrons</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Marked hypertriglyceridemia</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Familial Hypercholesterolemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old man has Lipoprotein lipase deficiency.<br>Which one of the following features is most likely?</span></p>",
      "unique_key": "DT1196930",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196930,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>LPL deficiency</strong> leads to <strong>accumulation of triglyceride-rich chylomicrons</strong>, causing <strong>severe hypertriglyceridemia</strong>.</p>\r\n<p><strong>Lipoprotein lipase (LPL)</strong> is the key enzyme responsible for hydrolyzing <strong>triglycerides</strong> in chylomicrons and VLDL particles into free fatty acids.</p>\r\n<ul>\r\n<li>In <strong>LPL deficiency</strong> (also called <strong>familial chylomicronemia syndrome</strong>):\r\n<ul>\r\n<li>Chylomicrons <strong>cannot be cleared from plasma</strong></li>\r\n<li>Leads to <strong>marked hypertriglyceridemia</strong>, often &gt;1000 mg/dL</li>\r\n<li>Risk of <strong>acute pancreatitis</strong>, <strong>eruptive xanthomas</strong>, <strong>lipemia retinalis</strong></li>\r\n</ul>\r\n</li>\r\n<li>Inheritance is <strong>autosomal recessive</strong></li>\r\n<li>Similar phenotype also seen in:\r\n<ul>\r\n<li><strong>ApoC-II deficiency</strong></li>\r\n<li><strong>ApoA5 deficiency</strong></li>\r\n<li><strong>GPIHBP1</strong> or <strong>lipase maturation factor 1</strong> mutations</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Marked hypercholesterolemia (Option A):</strong> Seen in <strong>familial hypercholesterolemia</strong>, not in LPL deficiency.</p>\r\n<p><strong>Reduced chylomicrons (Option B):</strong> LPL deficiency causes <strong>elevated chylomicrons</strong>, not reduced.</p>\r\n<p><strong>Familial Hypercholesterolemia (Option D):</strong> Different disorder involving <strong>LDL receptor pathway</strong>, not triglyceride clearance.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>LPL deficiency</strong> causes <strong>massive hypertriglyceridemia</strong> due to failure to clear chylomicrons, often presenting with pancreatitis and eruptive xanthomas.</p>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Apoprotein E</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Apoprotein CII</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Apoprotein AII</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Lipoprotein B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which one of the following protein defects is most likely to be associated with very high levels of plasma chylomicrons?</span></p>",
      "unique_key": "DT1196934",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196934,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Apoprotein CII</strong> is a critical <strong>activator of lipoprotein lipase</strong>, and its deficiency leads to <strong>accumulation of chylomicrons</strong> in plasma.</p>\r\n<p><strong>Chylomicrons</strong> are large triglyceride-rich lipoproteins synthesized in intestinal epithelial cells to transport <strong>dietary fats</strong>.</p>\r\n<ul>\r\n<li><strong>Lipoprotein lipase (LPL)</strong> is required to hydrolyze triglycerides in chylomicrons</li>\r\n<li><strong>Apoprotein CII</strong> acts as a <strong>cofactor for LPL activation</strong></li>\r\n<li>In its absence, <strong>LPL is inactive</strong>, leading to:\r\n<ul>\r\n<li><strong>Accumulation of chylomicrons in plasma</strong></li>\r\n<li>Severe <strong>hypertriglyceridemia</strong></li>\r\n<li>Risk of <strong>pancreatitis</strong>, <strong>eruptive xanthomas</strong>, <strong>lipemia retinalis</strong></li>\r\n</ul>\r\n</li>\r\n<li>This resembles the phenotype seen in <strong>familial LPL deficiency</strong>, but occurs slightly later in life</li>\r\n<li><strong>Management</strong>: Strict <strong>low-fat diet</strong> with <strong>medium-chain triglycerides (MCTs)</strong> that bypass chylomicron transport</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Apoprotein E (Option A):</strong> Involved in remnant uptake; mutations lead to <strong>Type III dysbetalipoproteinemia</strong>, not chylomicronemia</p>\r\n<p><strong>Apoprotein AII (Option C):</strong> Component of HDL, not involved in chylomicron metabolism</p>\r\n<p><strong>Lipoprotein B (Option D):</strong> Refers to ApoB100 (VLDL, LDL) and ApoB48 (chylomicrons); mutations affect synthesis but not LPL activation</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Apoprotein CII deficiency</strong> results in failure to activate <strong>lipoprotein lipase</strong>, causing <strong>severe chylomicronemia</strong> and <strong>hypertriglyceridemia</strong>.</p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\"> Warfarin</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Antacids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You review a 67-year-old man for dyslipidemia. He is taking atorvastatin 40 mg/day. Which of the following drugs should be used with caution?</span></p>",
      "unique_key": "DT1196938",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196938,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Erythromycin</strong> is a potent <strong>CYP3A4 inhibitor</strong> that <strong>increases statin plasma levels</strong>, raising the risk of <strong>myopathy and rhabdomyolysis</strong>.<strong><br /> </strong>&nbsp;Statins, including <strong>atorvastatin</strong>, are metabolized by the <strong>cytochrome P450 3A4</strong> enzyme system.</p>\r\n<ul>\r\n<li><strong>CYP3A4 inhibitors</strong> (e.g., erythromycin, azole antifungals, HIV protease inhibitors) <strong>reduce statin clearance</strong> &rarr; &uarr; <strong>statin concentration</strong> &rarr; &uarr; risk of <strong>myopathy and rhabdomyolysis</strong></li>\r\n<li>Caution is essential when combining these drugs with <strong>moderate to high-dose statins</strong> (e.g., atorvastatin 40-80 mg/day)</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Warfarin (Option A):</strong> Statins may <strong>potentiate warfarin's effect</strong>, requiring <strong>INR monitoring</strong>, but do <strong>not increase myopathy risk</strong>.</p>\r\n<p><strong>Digoxin (Option C):</strong> Statins can slightly increase digoxin levels via <strong>P-glycoprotein inhibition</strong>, but <strong>myopathy risk is not significantly increased</strong>.</p>\r\n<p><strong>Antacids (Option D):</strong> Do <strong>not significantly interact</strong> with statins and are considered safe.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Erythromycin significantly increases the risk of statin-induced myopathy</strong> due to <strong>CYP3A4 inhibition</strong> and should be used cautiously with atorvastatin.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">An excess of LDL receptors</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased PCSK9 degradation</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of the LDL receptors to move to the cell surface</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Abnormal receptor-binding to LDL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old man is referred after his first myocardial infarction for your opinion. He has a total cholesterol level of 370 mg/dl, with normal triglycerides. You note the presence of corneal arcus and tendon xanthomas.<br>Which of the following genetic factors is not likely to be a cause of hypercholesterolemia?</span></p>",
      "unique_key": "DT1196942",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196942,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Increased LDL receptors</strong> would <strong>enhance clearance of LDL</strong>, and thus <strong>reduce</strong> serum cholesterol-not cause hypercholesterolemia.<strong><br /> </strong> This patient likely has familial hypercholesterolemia (FH), an autosomal dominant disorder caused by defective LDL receptor pathway.</p>\r\n<ul>\r\n<li><strong>Pathophysiology:</strong>\r\n<ul>\r\n<li>LDLR mutations &rarr; &darr; LDL uptake by hepatocytes</li>\r\n<li>APOB mutations &rarr; defective binding of LDL to receptor</li>\r\n<li>PCSK9 gain-of-function mutations &rarr; increased degradation of LDL receptors</li>\r\n<li>LDLRAP1 mutations (autosomal recessive FH) &rarr; impaired receptor internalization</li>\r\n</ul>\r\n</li>\r\n<li><strong>Clinical features:</strong>\r\n<ul>\r\n<li>Very high LDL levels</li>\r\n<li>Normal triglycerides</li>\r\n<li>Tendon xanthomas, corneal arcus, early MI</li>\r\n<li>Heterozygotes: CHD in 30s-40s</li>\r\n<li>Homozygotes: Severe CHD in childhood</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Increased PCSK9 degradation (Option B):</strong> Gain-of-function mutations lead to <strong>accelerated LDL receptor breakdown</strong>, causing hypercholesterolemia.</p>\r\n<p><strong>Failure of LDL receptors to move to the cell surface (Option C): </strong>A known mutation class in FH impairs receptor transport.</p>\r\n<p><strong>Abnormal receptor-binding to LDL (Option D):</strong> Occurs in <strong>APOB-related FH</strong>, where LDL cannot bind the receptor properly.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Excess LDL receptors</strong> enhance LDL clearance and <strong>do not cause hypercholesterolemia</strong> unlike mutations that reduce receptor number/function or increase their degradation.</p>",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes mellitus</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Bendrofluazide</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrotic syndrome</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following secondary causes of hyperlipidemia result in predominantly hypercholesterolemia, as opposed to hypertriglyceridemia?</span></p>",
      "unique_key": "DT1196949",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196949,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Nephrotic syndrome</strong> is a classical secondary cause of <strong>predominant hypercholesterolemia</strong> due to hepatic overproduction of lipoproteins in response to hypoalbuminemia.<strong><br /> </strong> <strong>Secondary hyperlipidemias</strong> may present with either <strong>predominantly raised cholesterol</strong> or <strong>raised triglycerides</strong>, depending on the underlying condition:</p>\r\n<ul>\r\n<li><strong>Hypercholesterolemia-dominant causes:</strong>\r\n<ul>\r\n<li><strong>Nephrotic syndrome</strong></li>\r\n<li><strong>Hypothyroidism</strong></li>\r\n<li><strong>Cholestatic liver disease<br /> </strong>These conditions upregulate hepatic production of apolipoprotein B-containing lipoproteins (e.g., LDL).</li>\r\n</ul>\r\n</li>\r\n<li>In <strong>nephrotic syndrome</strong>, hypoalbuminemia stimulates:\r\n<ul>\r\n<li>Hepatic lipoprotein synthesis</li>\r\n<li>Reduced clearance of LDL<br /> &rarr; Resulting in <strong>elevated LDL and total cholesterol</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Diabetes mellitus (Option A):</strong> Typically causes <strong>hypertriglyceridemia</strong>, especially in <strong>insulin resistance</strong>, due to increased VLDL and decreased lipoprotein lipase activity.</p>\r\n<p><strong>Bendrofluazide (Option B):</strong> A thiazide diuretic that causes <strong>mild hypertriglyceridemia</strong> and occasionally raises LDL levels.</p>\r\n<p><strong>Alcohol (Option D):</strong> Elevates <strong>triglycerides</strong>, especially via hepatic overproduction of VLDL and impaired clearance.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Nephrotic syndrome</strong> is a secondary cause of <strong>hypercholesterolemia</strong>, while conditions like <strong>diabetes and alcohol use</strong> cause <strong>hypertriglyceridemia</strong>.</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}